Trial Outcomes & Findings for Feasibility of a New Ambulatory Multi-vital Signs Monitor (NCT NCT05562011)

NCT ID: NCT05562011

Last Updated: 2023-12-20

Results Overview

Number of participants who had the presence of (data existing for at least 70% of 5-minute time periods) for all of the vital signs of interest together--heart rate (HR), blood pressure (BP), respiratory rate (RR), arterial oxygen saturation (SaO2) after placement of the device on the subject's wrist and hand.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

61 participants

Primary outcome timeframe

Baseline

Results posted on

2023-12-20

Participant Flow

Participant milestones

Participant milestones
Measure
Caretaker Device
participants will undergo active CarTaker monitoring for 24-48 hours
Overall Study
STARTED
61
Overall Study
COMPLETED
39
Overall Study
NOT COMPLETED
22

Reasons for withdrawal

Reasons for withdrawal
Measure
Caretaker Device
participants will undergo active CarTaker monitoring for 24-48 hours
Overall Study
Withdrawal by Subject
3
Overall Study
Lost to Follow-up
1
Overall Study
Could not co-enroll with other research study--device could not be placed postop
1
Overall Study
Device not placed postop due to patient being discharged home after surgery (not staying overnight)
4
Overall Study
Device malfunction
13

Baseline Characteristics

Feasibility of a New Ambulatory Multi-vital Signs Monitor

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Caretaker Device Placement
n=61 Participants
Caretaker Device placement: placement of the Caretaker device at preanesthesia visit and again postoperatively
Age, Continuous
62.1 years
STANDARD_DEVIATION 14.1 • n=5 Participants
Sex: Female, Male
Female
39 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
3 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
23 Participants
n=5 Participants
Race (NIH/OMB)
White
31 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
Region of Enrollment
United States
61 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Number of participants who had the presence of (data existing for at least 70% of 5-minute time periods) for all of the vital signs of interest together--heart rate (HR), blood pressure (BP), respiratory rate (RR), arterial oxygen saturation (SaO2) after placement of the device on the subject's wrist and hand.

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Preoperative Caretaker Monitor Placement Success
39 Participants

PRIMARY outcome

Timeframe: Pre-Op Hour 24

Participants' description of ease of use (interfered with Activities of Daily Living (ADLs) or sleep) in Yes/No format. Data will be collected to demonstrate percent of patients who answered "Yes" to Sleep or ADL interference. Free text will also be recorded for qualitative purposes. Shows Caretaker Feasibility.

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Ease of Use Determined by Number of Participants With Sleep or Activities of Daily Living (ADLs) Interference
16 Participants

PRIMARY outcome

Timeframe: Post-Op Hour 24

Population: Data not collected

Using postoperative nurse verbal feedback on usability of the Caretaker monitor on subjects scheduled for surgery during the perioperative period. Percent of nurses who answer yes to the question: Did you have any difficulty using the Caretaker monitor?

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Pre-Op Hour 24

Population: data not collected

Number of participants with no missing values expressed

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Intraoperative; from the time the Operating Room monitors are placed on the patient until they come off at the end of the case, an average of 2 hours

Number of participants with no missing values expressed

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Caretaker Data Capture Rate
39 Participants

PRIMARY outcome

Timeframe: Post-Op Hour 24

Population: data not collected

Number of participants with no missing values expressed

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Baseline through Pre-Op Hour 24

Percent of monitors returned to our research technicians

Outcome measures

Outcome measures
Measure
Caretaker Device
n=61 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Monitor Return Rate
61 Participants

SECONDARY outcome

Timeframe: Pre-Op hour 24, Post-Op Hour 24

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Heart Rate
Pre-Op Hour 24
94 beats per minute
Standard Deviation 19
Heart Rate
Post-Op Hour 24
87 beats per minute
Standard Deviation 15

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Percentage of time heart rate is \<60 bpm or \>90 bpm

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Heart Rate--percent of Time Parameters
Pre-Op Hour 24
55 percentage of time
Standard Deviation 3
Heart Rate--percent of Time Parameters
Post-Op Hour 24
40 percentage of time
Standard Deviation 4

SECONDARY outcome

Timeframe: Pre-Op hour 24, Post-Op Hour 24

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Respiratory Rate
Pre-Op Hour 24
17 respirations per minute
Standard Deviation 4
Respiratory Rate
Post-Op Hour 24
17 respirations per minute
Standard Deviation 4

SECONDARY outcome

Timeframe: Pre-Op hour 24, Post-Op Hour 24

Percent of time respirations are \<8 rpm or \>20 rpm

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Respiratory Rate--Percent of Time Parameters
Pre-Op Hour 24
21.6 percentage of time
Standard Deviation 3.8
Respiratory Rate--Percent of Time Parameters
Post-Op Hour 24
15.9 percentage of time
Standard Deviation 3.5

SECONDARY outcome

Timeframe: Post-Op Hour 24

Population: data not collected

oxygen saturation level as detected by the pulse oximeter

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Population: data not collected for either time point

Percentage of time SaO2 is between 95-100%

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Non-Invasive Systolic Blood Pressure (SBP)
Pre-Op Hour 24
119 units of millimeters of mercury (mmHg)
Standard Deviation 22
Non-Invasive Systolic Blood Pressure (SBP)
Post-Op Hour 24
134 units of millimeters of mercury (mmHg)
Standard Deviation 24

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Non-Invasive Mean Arterial Blood Pressure (MBP)
Pre-Op Hour 24
82 mm of Hg
Standard Deviation 18
Non-Invasive Mean Arterial Blood Pressure (MBP)
Post-Op Hour 24
97 mm of Hg
Standard Deviation 21

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Non-Invasive Diastolic Blood Pressure (DBP)
Post-Op Hour 24
68 mm of Hg
Standard Deviation 16
Non-Invasive Diastolic Blood Pressure (DBP)
Pre-Op Hour 24
58 mm of Hg
Standard Deviation 16

SECONDARY outcome

Timeframe: Pre-Op Hour 24, Post-Op Hour 24

Percent time MBP is \<60 mmHg and/or \>90 mmHg

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Non-Invasive Blood Pressure--MBP Percent of Time Parameters
Pre-Op Hour 24
37 percentage of time
Standard Deviation 4
Non-Invasive Blood Pressure--MBP Percent of Time Parameters
Post-Op Hour 24
67 percentage of time
Standard Deviation 1

SECONDARY outcome

Timeframe: Day 30

Percent declared dead

Outcome measures

Outcome measures
Measure
Caretaker Device
n=61 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Mortality Rate
0 Participants

SECONDARY outcome

Timeframe: Up to Postoperative Day 30

Number of days from hospital admission to discharge

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Average Length of Hospital Stay
3.5 number of days
Standard Deviation 4.3

SECONDARY outcome

Timeframe: Up to Postoperative Day 30

Percent of study participants transferred to an ICU during their hospital stay

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
ICU Transfer Rate
10 Participants

SECONDARY outcome

Timeframe: During hospitalization up to Postoperative Day 30

Number of calls made to the hospital's "Rapid Response Team" (RRT) during subjects' hospital stay. The RRT is called by nurses if the patient is experiencing stroke-like symptoms, chest pain refractory to medical treatment, or vital signs (HR, RR, BP, SaO2) meeting a pre-defined out of range value.

Outcome measures

Outcome measures
Measure
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
Number of Rapid Response Team Calls
2 calls

Adverse Events

Caretaker Device

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Timothy Harwood, M.D.

Wake Forest University School of Medicine

Phone: 336.716.8830

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place